Jenburkt Pharmaceuticals Ltd
NSE: BSE: 524731
₹1004
(0.93%)
Sun, 08 Mar 2026, 04:32 pm
Market Cap4.43B
PE Ratio13.67
Dividend1.79
Health Technology
Pharmaceuticals: Major
24.5KJenburkt Pharmaceuticals Income Statement
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 290.69M | 354.16M | 383.86M | 415.21M | 514.02M | 564.24M | 597.56M | 692.70M | 762.00M | 850.18M | 929.41M | 1.03B | 1.15B | 1.23B | 1.19B | 1.09B | 1.24B | 1.37B | 1.42B | 1.52B |
| Gross profit | 18.46M | 24.74M | 29.08M | 35.53M | 181.22M | 226.74M | 244.26M | 272.99M | 303.32M | 356.94M | 399.33M | 443.94M | 500.36M | 532.42M | 459.09M | 439.40M | 529.14M | 611.16M | 652.54M | 719.07M |
| Operating expenses (excl. COGS) | -1.80M | -1.90M | -3.30M | -4.68M | -124.98M | -139.50M | -152.10M | -187.43M | -203.93M | -232.93M | -261.10M | -261.45M | -276.22M | -293.13M | -279.20M | -251.85M | -275.44M | -325.08M | -338.99M | -334.13M |
| Selling/general/admin expenses, total | — | — | — | — | -123.81M | -137.89M | -152.10M | -187.43M | -203.93M | -232.93M | -261.10M | -261.45M | -276.22M | -293.13M | -279.20M | -251.85M | -275.44M | -325.08M | -338.99M | -334.13M |
| Research & development | -199.00K | -193.00K | -380.00K | -1.30M | -3.38M | -5.75M | -4.64M | -5.16M | -6.18M | -7.00M | -7.26M | -7.67M | -7.64M | -8.28M | -9.25M | -9.85M | -10.81M | -12.26M | -12.32M | -4.34M |
| Selling/general/admin expenses, other | — | — | — | — | -120.43M | -132.14M | -147.47M | -182.28M | -197.75M | -225.93M | -253.84M | -253.79M | -268.58M | -284.85M | -269.95M | -242.00M | -264.63M | -312.82M | -326.67M | -329.79M |
| Other operating expenses, total | -1.80M | -1.90M | -3.30M | -4.68M | -1.17M | -1.60M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | 16.66M | 22.84M | 25.78M | 30.84M | 56.24M | 87.24M | 92.15M | 85.56M | 99.39M | 124.02M | 138.23M | 182.48M | 224.14M | 239.28M | 179.89M | 187.55M | 253.71M | 286.08M | 313.55M | 384.94M |
| Non-operating income, total | -1.56M | -4.24M | -5.82M | -4.12M | 1.03M | 3.65M | -6.95M | 2.68M | 3.90M | 19.38M | 30.05M | 22.31M | 28.55M | 27.05M | 31.49M | 28.87M | 45.00M | 42.56M | 38.21M | 54.39M |
| Interest expense, net of interest capitalized | -6.91M | -8.62M | -8.18M | -8.92M | -5.44M | -5.36M | -6.02M | -6.63M | -12.65M | -3.56M | -3.78M | -4.10M | -4.12M | -3.86M | -5.26M | -4.74M | -4.34M | -3.67M | -2.71M | -4.53M |
| Interest capitalized | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 5.34M | 4.38M | 2.36M | 4.81M | 6.47M | 9.02M | -1.84M | 8.75M | 16.35M | 22.93M | 33.83M | 26.30M | 32.56M | 30.87M | 36.74M | 33.48M | 48.98M | 45.21M | 40.03M | 58.38M |
| Non-operating interest income | 2.07M | 1.68M | 2.71M | 2.65M | 2.25M | 3.65M | 6.68M | 9.14M | 13.37M | 19.84M | 25.10M | 27.83M | 28.95M | 32.05M | 36.35M | 40.53M | 43.71M | 40.20M | 41.27M | 52.62M |
| Miscellaneous non-operating expense | 3.27M | 2.70M | -349.00K | 2.15M | 4.22M | 5.36M | -8.52M | -391.00K | 2.98M | 3.09M | 8.73M | -1.53M | 3.61M | -1.18M | 383.00K | -7.04M | 5.27M | 5.01M | -1.23M | 5.76M |
| Unusual income/expense | — | — | — | — | — | — | 916.00K | 560.00K | 193.00K | 18.00K | 0 | 103.00K | 107.00K | 41.00K | 10.00K | 119.00K | 363.00K | 1.02M | 885.00K | 529.00K |
| Pretax income | 15.10M | 18.61M | 19.96M | 26.73M | 57.27M | 90.90M | 85.21M | 88.24M | 103.29M | 143.40M | 168.28M | 204.79M | 252.69M | 266.33M | 211.38M | 216.42M | 298.71M | 328.65M | 351.76M | 439.33M |
| Taxes | -4.70M | -6.57M | -6.93M | -10.37M | -21.47M | -30.75M | -25.25M | -26.09M | -28.23M | -46.91M | -60.49M | -69.71M | -80.57M | -68.36M | -62.68M | -51.39M | -75.74M | -82.58M | -91.99M | -118.72M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 10.40M | 12.04M | 13.03M | 16.36M | 35.80M | 60.15M | 59.95M | 62.15M | 75.06M | 96.49M | 107.79M | 135.08M | 172.12M | 197.98M | 148.70M | 165.02M | 222.97M | 246.07M | 259.77M | 320.61M |
| Net income | 10.40M | 12.04M | 13.03M | 16.36M | 35.80M | 60.15M | 59.95M | 62.15M | 75.06M | 96.49M | 107.79M | 135.08M | 172.12M | 197.98M | 148.70M | 165.02M | 222.97M | 246.07M | 259.77M | 320.61M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 10.40M | 12.04M | 13.03M | 16.36M | 35.80M | 60.15M | 59.95M | 62.15M | 75.06M | 96.49M | 107.79M | 135.08M | 172.12M | 197.98M | 148.70M | 165.02M | 222.97M | 246.07M | 259.77M | 320.61M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 22.04M | 29.51M | 32.19M | 37.58M | 64.49M | 97.07M | 104.33M | 100.39M | 114.92M | 150.61M | 158.15M | 200.35M | 239.14M | 252.81M | 202.88M | 207.90M | 272.69M | 308.68M | 336.94M | 412.22M |
| EBIT | 16.66M | 22.84M | 25.78M | 30.84M | 56.24M | 87.24M | 92.15M | 85.56M | 99.39M | 124.02M | 138.23M | 182.48M | 224.14M | 239.28M | 179.89M | 187.55M | 253.71M | 286.08M | 313.55M | 384.94M |
| Total operating expenses | -274.03M | -331.32M | -358.08M | -384.37M | -457.78M | -477.00M | -505.41M | -607.14M | -662.61M | -726.16M | -791.18M | -850.58M | -922.60M | -987.16M | -1.01B | -905.39M | -986.10M | -1.08B | -1.11B | -1.13B |
| Prepaid expenses | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | 4.64M | 6.37M | 4.90M | 4.82M | 4.36M | 5.53M | 5.97M | 6.77M | 11.59M |
| Deferred income, current | — | — | — | — | — | — | — | — | — | — | — | — | 4.92M | 197.00K | 8.28M | 12.06M | 8.59M | 578.00K | 6.10M | 3.00K |
| Capital and operating lease obligations | 392.00K | 392.00K | 759.00K | 954.00K | 1.46M | 953.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.40M | 4.89M | 4.89M | 0 | 0 | 14.92M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 4.83M | 5.00M | 5.13M | 5.00M | 6.98M | 11.52M | 11.99M | 11.71M | 11.97M | 7.63M | 7.34M | 5.03M | 1.18M | — | 2.38M | 8.21M | 8.56M | 7.17M | 7.90M | 10.87M |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | — | — | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -5.81M | -5.81M | -5.81M | -8.37M | 0 | -16.27M | -16.27M | -19.53M | -27.56M | -35.25M | -40.29M | 0 | -76.61M | -20.26M | -103.08M | 0 | -46.80M | -55.00M | -63.18M | -67.81M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800